Stephen Feider, Chief Financial Officer at Beta Bionics, Inc. (BBNX), sold 1,497 shares at $18.69 ($27K) on 2025-06-02, disclosed to the SEC on 2025-06-04.
Open-market sale of $27k BBNX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.03 | 410 | $7K | 26.1% |
| 2 | $18.15 | 951 | $17K | 64.4% |
| 3 | $18.69 | 136 | $3K | 9.5% |
| Total | $17.89 avg | 1,497 | $27K | 100% |
| Filing → |
| BBNX | SELL | 2026-06-03 | $84K | — | Filing → |
| BBNX | SELL | 2026-03-03 | $18K | — | Filing → |
| BBNX | SELL | 2026-01-05 | $591K | — | Filing → |